Ching-Liang Ho

3PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 06, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

|Dec 09, 2025
Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World Survival and Safety Outcomes.

Ren-Hua Ye, Hong-Jie Jhou, Hsin-Yu Chen

|Sep 30, 2024
Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521.

Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang

Pageof 1

Frequent Collaborators

2 joint publications

Hong-Jie Jhou

2 joint publications

Li-Ting Kao

2 joint publications

Cho-Hao Lee

2 joint publications

Po-Huang Chen